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Abstract
Background: Aging is associated with decreased muscle mass and functional capacity, which in turn decrease
quality of life. The number of citizens over the age of 65 years in the Western world will increase by 50 % over the
next four decades, and this demographic shift brings forth new challenges at both societal and individual levels.
Only a few longitudinal studies have been reported, but whey protein supplementation seems to improve muscle
mass and function, and its combination with heavy strength training appears even more effective. However, heavy
resistance training may reduce adherence to training, thereby attenuating the overall benefits of training. We
hypothesize that light load resistance training is more efficient when both adherence and physical improvement
are considered longitudinally. We launched the interdisciplinary project on Counteracting Age-related Loss of
Skeletal Muscle Mass (CALM) to investigate the impact of lifestyle changes on physical and functional outcomes as
well as everyday practices and habits in a qualitative context.
Methods: We will randomize 205 participants older than 65 years to be given 1 year of two daily nutrient
supplements with 10 g of sucrose and 20 g of either collagen protein, carbohydrates, or whey. Further, two groups
will perform either heavy progressive resistance training or light load training on top of the whey supplement.
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Discussion: The primary outcome of the CALM Intervention Study is the change in thigh cross-sectional area.
Moreover, we will evaluate changes in physical performance, muscle fiber type and acute anabolic response to
whey protein ingestion, sensory adaptation, gut microbiome, and a range of other measures, combined with
questionnaires on life quality and qualitative interviews with selected subjects. The CALM Intervention Study will
generate scientific evidence and recommendations to counteract age-related loss of skeletal muscle mass in elderly
individuals.
Trial registration: ClinicalTrials.gov NCT02034760. Registered on 10 January 2014.
ClinicalTrials.gov NCT02115698. Registered on 14 April 2014.
Danish regional committee of the Capital Region H-4-2013-070. Registered on 4 July 2013.
Danish Data Protection Agency 2012-58-0004 – BBH-2015-001 I-Suite 03432. Registered on 9 January 2015.
Keywords: Elderly, Protein, Whey, Muscle, Strength training, Gut microbiome, Plasma metabolome
Background
On the basis of demographic extrapolations, the number
of elderly citizens above the age of 65 years will increase
in the next three decades by 50–200 %, with the specific
proportion being dependent on country [1, 2]. With bio-
logical aging, physical function often decreases. This in-
creases the risk of developing frailty [3], indicating
higher risk for adverse events. Even in healthy, active,
and independently living older people, a gradual loss of
muscle mass, termed sarcopenia [4], takes place at an
annual rate of up to 1–2 % starting in the sixth decade
of life [5–7]. The loss of muscle mass is accompanied by
an even faster deterioration of muscle strength of up to
3.5 % per year [8]. If allowed to progress, the develop-
ment of sarcopenia is associated with increased risk of
falling [9], decreased satisfaction with life [10], and even
an increased mortality rate [11]. The impact of sarcope-
nic progression may become detrimental to an individ-
ual’s personal life and autonomy, and the societal
implications are vast when one considers future health-
care and nursing expenditures. Therefore, in the present
study, we aim to test the efficacy and feasibility of differ-
ent strategies for counteracting muscular deterioration.
Preferably, these strategies should be easy to integrate
into everyday life for the majority of the aging popula-
tion to induce maximal efficiency at both individual and
societal levels.
Previous research has described the multifactorial na-
ture of the development of sarcopenia [12–14]. On the
basis of the aging muscle becoming less sensitive to daily
anabolic stimuli due to protein intake [15] and muscular
activity [16, 17], it is suggested that exactly these two
factors possess a high potential to antagonize sarcopenia.
Further, the nutrition and exercise training strategies are
self-manageable, allowing a certain degree of flexibility
for adjustment to personal preferences and everyday
practices. Although their mutual dependency is acknowl-
edged [18, 19], the “dosing” of each factor remains ques-
tionable, and the impact during long-term exposure is
unknown. In contrast to studies of strategies used for
treating individuals who already have loss of muscle
mass and function, the aim of the Counteracting Age-
related Loss of Skeletal Muscle Mass (CALM) Interven-
tion Study is to evaluate strategies to prevent sarcopenic
progression in healthy, independently living aging
individuals.
With regard to protein intake, cohort studies strongly
suggest an association between high protein intake and de-
creased rates of age-dependent decline in physical perform-
ance and reduced risk of frailty [20–22]. However,
researchers in intervention studies have reported inconclu-
sive effects on physical function and muscle mass after ad-
ministering protein supplements for longer periods [23–
25]. Research has shown that ingestion of 10 g of essential
amino acids [26], corresponding to roughly 20 g of whey
protein or even 35–40 g of dairy protein at rest [27] or after
exercise [28], can stimulate muscle protein synthesis (MPS)
fully. The quality of the ingested protein is a matter of con-
cern, and the protein digestibility-corrected amino acid
score (PDCAAS) [29] is a way to evaluate this. Protein
amino acid composition and protein digestibility are the
two notable factors that determine the PDCAAS, but using
hydrolyzed protein maximizes protein digestibility, espe-
cially for proteins with slow digestibility, such as casein,
leaving amino acid composition as the most important fac-
tor for the protein of choice when investigating the effect
on muscle mass. Research has shown that whey protein ap-
pears advantageous in comparison with other protein
sources [30, 31]. While the focus has been mainly on pro-
tein type and quantity, experimental results combined with
eating patterns of elderly persons recently led to the hy-
pothesis that intake distribution may be of importance [32].
In Denmark, calculations suggest that citizens between 65
and 75 years of age consume a mean of 1.1 g of protein per
kilogram of body weight per day [33, 34], indicating that
the average senior citizen consumes a reasonable amount
of protein [13, 35–37]. This amount is well above the
present recommended dietary allowance of 0.8 g/kg body
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weight [29, 38], which is based on the estimated average re-
quirements ±2 SD. The pattern of protein ingestion is not
currently mentioned in recommendations, and data derived
from elderly citizens in the United States [39] and Denmark
(Fagt S, Danskernes Kostvaner 2011-2013, unpublished
data) demonstrate that almost half of the daily amount of
protein is ingested at dinner. The implications of this may
be that the MPS is maximally stimulated only once daily
[27, 40, 41], despite daily average protein consumption
appearing to be adequate. Therefore, we hypothesize that a
recommendation for enhanced daily protein intake should
include a guideline for an evenly distributed protein intake
throughout the day to optimize muscle protein accretion
[42, 43]. Promoting a healthier eating pattern may be suc-
cessful in improving food choices, but this has a modest
success in terms of actual lifestyle changes [44]. Therefore,
if research should convert any new knowledge on the
timely provision of additional protein intake into actual
changes in daily eating patterns and life routines in the eld-
erly target group, scientists must take into account the
short-term (weeks) and long-term (months) acceptability of
daily ingestion of food supplements. Additionally, to de-
scribe the impact of daily supplementation with protein on
general health, researchers should also investigate additional
benefits or compromising side effects of the protein intake.
Heavy load muscle training is undoubtedly the most
effective exercise strategy to gain muscle mass and
strength [45–48], and even very old individuals can
benefit from training by experiencing an increase in
muscle mass and strength [18, 19, 49–52]. However, at
a societal level, the overall impact of implementing a
certain training regime reflects a balance between the
stimulatory effect of exercise training per se and toler-
ability and adherence to the training modality and set-
ting. Activities of more moderate intensity, preferably
those that are simple, convenient, and cheap [53], are
associated with increased participation among the eld-
erly. Further, these activities should be performed in an
informal setting [54], and sessions in a training program
seeking high adherence should be either home-based or
conducted in smaller groups with peers [55, 56]. There-
fore, despite an increased training effect per se, the
feasibility of heavy load strength training requiring ad-
mittance to a fitness center or similar facility may be
questionable for the elderly population [57]. As demon-
strated in Fig. 1, home-based light load resistance train-
ing may prove to be a better recommendation for
preventing age-related decreases in muscle mass and
physical function because of increased adherence, but
longitudinal research in the elderly is lacking.
We have launched a 1-year longitudinal randomized
controlled trial (RCT), partly single-blinded/partly
double-blinded, to investigate the impact of protein
quality and training intensity on different variables.
The primary outcome measure is the change in knee
extensor skeletal muscle cross-sectional area (CSA)
over the course of 1 year of intervention. The sec-
ondary and tertiary outcomes are listed in the Mea-
surements section below. In this RCT, we are
integrating the evaluation of the interventions’ impact
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WHEY per-protocol
COLL per-protocol
CARB per-protocol
Fig. 1 Hypothesized improvements over time with different interventions. Black lines mark the expected effect of per-protocol analysis: HRTW
(solid line), LITW (long-dashed line), WHEY (short-dashed line), COLL (dashed-dotted line), and CARB (dotted line) interventions when analyzed per
protocol. The gray line marks the expected effect intention-to-treat analysis of HRTW. CARB carbohydrate supplementation group, COLL collagen
supplementation group, HRTW heavy resistance training with whey supplementation, LITW light-intensity training with whey supplementation,
WHEY whey supplementation
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on general health, physical and functional parameters,
and impact on daily life routines and practices as well
as on the acceptability of the interventions, covering
the entire spectrum from objective physiological mea-
sures to subjective investigations on the participants.
All results will be fed into the integrative and inter-
disciplinary outcomes of the CALM Intervention
Study (Fig. 2).
Working hypotheses
We designed the CALM Intervention Study to investi-
gate two overarching working hypotheses:
1. Whey protein hydrolysate supplementation is more
efficient than collagen protein hydrolysate and carbohy-
drate in improving muscle size when administered to
healthy elderly individuals.
2. With whey protein hydrolysate supplementation,
the addition of center-based heavy resistance training is
advantageous to home-based light load resistance train-
ing, and both of these regimens are superior to no train-
ing at all, in regard to improving muscle mass, overall
health, and physiological parameters only with a per-
protocol analysis. This will not be the case in regard to
intention-to-treat analysis, where a markedly higher ad-
herence is presumed in the home-based training group,
leading to a similar or superior response compared to
the center-based heavy resistance training group.
Methods/design
Overview
The CALM Intervention Study is a single-center, partly
single- and partly double-blinded, multidisciplinary
RCT. Collaborators are affiliated with (1) the Faculty of
Science, Department of Food Science, (2) the Faculty of
Humanities, SAXO Institute, and (3) the Faculty of
Health and Medical Sciences, Department of Biomedical
Sciences, all at the University of Copenhagen and the In-
stitute of Sports Medicine Copenhagen, Bispebjerg Hos-
pital, Copenhagen, Denmark. We wrote the protocol
using the Standard Protocol Items: Recommendations
for Interventional Trials (SPIRIT) guidelines for clinical
trial protocols (http://www.spirit-statement.org/spirit-
statement) and registered the protocol at ClinicalTrials.-
gov. Any changes will be reported there and to the local
ethics committee.
Recruitment of participants
The CALM Intervention Study will include 205 partici-
pants living in the Greater Copenhagen area through
local newspapers, magazines, radio programs, social
media, and presentations at senior centers and public
events. See the Statistics and power calculations section
below for further explanation on recruitment require-
ments. Recruitment commenced in January 2014. Exclu-
sion criteria are listed in Table 1.
Information and screening
Upon first contact, a researcher informs the possible
participants briefly about the project and sends written
information by mail or e-mail. If the candidate is still in-
terested after having read the material, the staff member
subsequently screens for exclusion criteria and invites
the person to an information meeting after which
Fig. 2 Spectrum of outcome variables. In the interdisciplinary
Counteracting Age-related Loss of Skeletal Muscle Mass Intervention
Study, we are investigating the entire spectrum of possible impacts
of the intervention by applying objective, quantitative measures of
the body and subjective, qualitative investigations of the participants
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participants give their written informed consent in ac-
cordance with Declaration of Helsinki II. The protocol
has been approved by The Danish Regional Committees
of the Capital Region on 4 July 2013 (number H-4-2013-
070).
At the information meeting, a medical member of the
research team delivers the information verbally followed
by a health screening including blood pressure, blood
samples, and heart auscultation to determine if the can-
didate can safely complete the interventions. Then, the
participant performs a 30-second chair-stand test that
we use for stratified randomization only.
Randomization
Following screening and health examinations, we enroll
candidate participants and researchers who are not in-
volved in interventions or tests that are sensitive to blind-
ing randomize them using the open-source minimization
program MinimPy 0.3 [58, 59]. To ensure even distribu-
tion of subjects throughout the study period, we decided
to employ a stratified, biased coin minimization with 0.95
base probability and to use allocation ratios corresponding
to the group sizes (see Statistics and power calculations
section below). Participant stratification is based on a 30-
second chair-stand test (<16 or ≥16) and on gender to en-
sure equal allocation to one of the five intervention groups
and further to determine if the participant will participate
in invasive acute mechanistic MPS trials (see Muscle pro-
tein synthesis section below), as demonstrated in Fig. 3.
Interventions
The five intervention groups comprise the two arms of the
study. One arm concerns the importance of supplementa-
tion using the three supplementation-only groups: carbohy-
drate supplementation (CARB; 20 g maltodextrin + 10 g
sucrose), collagen supplementation (COLL; 20 g bovine col-
lagen protein hydrolysate + 10 g sucrose), and whey supple-
mentation (WHEY; 20 g whey protein hydrolysate + 10 g
sucrose). All supplements were developed, prepared, and
individually packaged by Arla Foods Ingredients Group P/
S, Viby J, Denmark. The other arm investigates the import-
ance of training loads and includes all groups supplemented
with the aforementioned whey supplements, either without
training (WHEY; the same group used in the supplementa-
tion arm), with light load home-based resistance training
four times weekly (LITW), or with center-based heavy re-
sistance training three times weekly (HRTW). Table 2
describes the training protocols in detail. All subjects
consume the supplements twice daily, namely in the
morning and at midday, preferably just before or
during meals to increase satiety, thereby avoiding ex-
cess intake of calories. Participants who exercise are
Table 1 Exclusion criteria
Criteria
1 Care dependency
2 Disability in lower extremities
3 Arthritis or arthrosis in knee or hip joints, arthritis requiring medication, or other rheumatic diseases potentially affecting joints or muscles
4 Diagnosed or suspected knee osteoarthritis (based on EULAR criteria: three symptoms and three signs); excluded if more than one of the
following thee symptoms are found: morning stiffness <30 minutes, persistent knee pain, or functional limitations
5 Bilateral knee alloplastic and hip alloplastic material
6 Connective tissue disorders
7 Severe COPD (FEV1/FVC ratio <70 % and FEV1 < 50 % of predicted value (GOLD stage 3 or 4)
8 Unstable cardiac arrhythmias or decreased LVEF (<60 %)
9 Gut diseases affecting food absorption
10 Surgical diseases affecting ability to conduct heavy load strength exercise
11 Embodied magnetic metal
12 Endocrinological diseases potentially affecting muscles (diabetes mellitus, growth hormone-treated, sex hormone-treated, or untreated thyroid
diseases)
13 Alcohol consumption >21 U/week for men and 14 U/week for women (1 U = 15.2 ml of alcohol)
14 Participation in studies using the same stable isotopically labeled tracers as this study (i.e., L-[ring-13C6]phenylalanine) within the last 6 months
15 Medications: systemic corticosteroids, sex hormone therapy, anti-sex hormone therapy, anticoagulants (thrombin inhibitors, K-vitamin antagonists,
heparins, pentasaccharides, factor Xa inhibitors, thrombocyte inhibitors except nonsteroidal anti-inflammatory drugs and acetylsalicylic acid).
16 >1 h of weekly heavy strength training
17 Dementia or other severe cognitive impairment
18 Not holding Danish citizenship or not fluent in Danish
Abbreviations: COPD chronic obstructive pulmonary disease, EULAR European League Against Rheumatism, FEV1 forced expiratory volume in 1 second, FVC forced
vital capacity, GOLD Global Initiative for Chronic Obstructive Lung Disease, LVEF left ventricular ejection fraction
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encouraged to take one supplement immediately after
each training session. We conduct all interventions
and tests at Bispebjerg Hospital. To report the im-
provement in thigh strength in repetition maximums
(RM), we measure the thigh 3 RM in the knee exten-
sor machine used for heavy resistance training (Super
Executive Line; TechnoGym, Cesena, Italy) using as
few attempts as possible every third month. To relate
to the commonly used 1 RM, we will convert the re-
sult to a 1-RM equivalent using the Brzycki formula
[60]: 1 RM = weight lifted × [36/(37 − repetitions)].
Participants monitor their adherence to protein sup-
plementation and their home-based exercise in hard-
copy diaries, whereas the trainers register the training
Fig. 3 Participant flow. Ntotal represents the expected number of inclusions in each group. Nacute represents the expected number of participants
who will complete the measurements of fractional synthesis rate at 0 and 12 months. COLL Collagen supplementation, CARB Carbohydrate
supplementation, WHEY Whey supplementation, LITW Light intensity resistance training and whey supplementation, HRTW Heavy resistance
training and whey supplementation
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adherence in the HRTW group. We stress the import-
ance of registering only the actual number of supple-
ments taken and exercises performed.
Blinding
We achieve blinding by storing the randomization log
file electronically without access for researchers
performing the tests who could be affected by not
being blinded. Specifically, blinded radiographers will
perform magnetic resonance imaging (MRI) scans at
the Department of Radiology, Bispebjerg-Frederiksberg
Hospital, Copenhagen, Denmark. A blinded physiotherapist
or physiologist will perform strength and functional
assessments, and only one tester will assess each
participant. Experienced staff not blinded to the inter-
vention will perform dual-energy X-ray absorpti-
ometry (DXA), muscle biopsies, anthropometry, and
blood sampling. Blinded investigators will perform all
analysis and interpretation of obtained data. We blind
participants in supplementation-only groups, as the
bags containing supplements are marked only by a
code, and only relevant researchers can access the key
file containing the explanation of the codes. For
obvious reasons, we did not blind those performing
Table 2 Exercise descriptions
Exercise regimen LITW (three to five times weekly) HRTW (three times weekly)
General comments We instruct weekly in the first month and thereafter
correct and instruct all exercises monthly, including one
home visit. We increase the load accordingly when
subjects can perform a given exercise correctly
(i.e., optimal range of motion) and steadily (i.e., no shaking
and maintaining a steady pace) as evaluated by the
instructor. We use red, green, and blue TheraBand® rubber
bands (Hygenic Corp., Akron, OH, USA). The weekly
number of training sequences varies between three and
five as follows: three, four, five, four, three, four, five, four,
etc. (i.e., on average, four times weekly).
Lower body exercises: All exercises progress from 3 sets of
12 repetitions at 12 RM load to 5 sets of 6 repetitions at 6
RM load in 3-month cycles. The final 2 weeks of each cycle
are tapering and testing periods with less intensive
training. Upper body exercises: All exercises progress from 3
sets of 12 repetitions (12 RM) to 4 sets of 10 repetitions
(10 RM).
Leg extension Sitting on a chair and using rubber bands mounted
around one leg of a chair and the relevant ankle, the
participant extends and flexes the knee joint continuously
and slowly. The exercise is performed three times for
1 minute each, separated by a break of similar duration,
where they train the opposite leg. We ensured progress
by decreasing the rubber band’s elasticity.
Super Executive Line (TechnoGym, Gambettola, Cesena,
Italy). We separate sets by approximately 2 minutes. At all
times, loading ensured training to fatigue. If participants
could perform more repetitions after the final set, we
added more weight at the next session.
Chair-stand/squat/leg press Without using the arms, participants rise from and sit
down on a chair continuously and slowly. They perform
the exercise three times for 1.5 minutes separated by
breaks of similar duration. We ensured progress by starting
with the participant on a high chair, then converting to a
low or no chair (i.e., squats).
Super Executive Line (TechnoGym, Gambettola, Cesena,
Italy): as described for leg extension
Leg curl Standing with rubber bands mounted around, for
example, the leg of a chair and the participant’s ankle, the
participant flexes and extends the knee joint continuously
and slowly. The exercise is performed three times for
1 minute separated by breaks of similar duration, where
they train the opposite leg. We ensured progress by
decreasing the rubber band’s elasticity.
MED Line (TechnoGym, Gambettola, Cesena, Italy): as
described for leg extension
Shoulder pull/pull-down Using rubber bands mounted around, for example, a
doorknob, the participant flexes and extends the elbow
joint continuously and slowly while keeping elbows
shoulder-wide. The participant performs the exercise three
times for 1.5 minutes separated by a break of similar
duration. We ensured progress by decreasing the rubber
band’s elasticity.
TR Equipment model 9014 (Tranås, Sweden): We separated
sets by a 2-minute break. At all times, loading ensured
training to fatigue. If participants could perform more
repetitions after the final set, we added more weight at
the next session.
Arm stretch/push-up Standing against a wall, the participant flexes and extends
the elbow joints continuously and slowly. The exercise is
performed three times for 1.5 minutes separated by breaks
of similar duration. We ensured progress by increasing the
distance to the wall, having the participant perform the
exercise on the floor while supporting on hands and
knees, or performing the exercise on the floor supporting
on hands and feet.
TR Equipment model 9025 (Tranås, Sweden): as described
for should pulldown
RM Repetition maximum
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exercises to intervention or supplement type, as
stated in the study hypotheses.
Measurements
This section describes each measurement performed to
evaluate the longitudinal effects of the chosen interven-
tions. Table 3 displays the time points for each examin-
ation. At baseline, we test the peak isometric and
isokinetic peak torques as well as leg extensor power in
both legs to evaluate if a large side difference between
thigh peak torques is associated with an improved or di-
minished response to the interventions.
Primary outcome
A change in muscle CSA is a direct reflection of the in-
tervention’s ability to restore muscle protein and a direct
consequence of the net protein balance over time in the
target muscles. We chose m. quadriceps and m. vastus
lateralis CSA based on MRI scans of the dominant thigh
as the primary outcome, as it directly reflects the inter-
vention’s ability to counteract age-related loss of muscle
mass. MRI scans have high sensitivity and validity in
terms of lean mass in skeletal muscle [61], and previous
researchers have considered this modality superior to
DXA [62, 63].
Table 3 Time schedule of participant engagement
Measurement Enrollment Baseline 6 months 12 months 18 months Other
Enrollment
Recruitment and screening X
Information and consent X
Primary outcome
MRI CSA of quadriceps femoris X X X X
Secondary outcomes
Thigh isometric peak torque X X X X
Thigh isokinetic peak torque X X X X
Thigh power X X X X
30-second chair-stand X X X X
Muscle biopsy X X
Body composition (DXA) X X X X
Bone mineral density (DXA) X X
Gut microbiome X X X
Fecal metabolome X X X
Plasma metabolome X X X
Acute muscle FSR X X
Tertiary outcomes
Blood samples X X X X
Anthropometry X X X X
Hand grip strength X X X X
400-m gait speed X X X X
SF-36 and PSQI X X
Activity monitoring X X X X
Registration of food consumption X X At week 6
Sensory questionnaires X X Weekly for 0–3 months
Satisfaction with Food-related Life scale X X X
Oral glucose tolerance test X X
Qualitative interview X X
Questionnaire on food habits X
Life story interviews Ad hoc
Ethnographic fieldwork Ad hoc
Abbreviations: MRI CSA magnetic resonance imaging cross-sectional area, DXA dual-energy X-ray absorptiometry, FSR fractional synthesis rate, PSQI Pittsburgh Sleep
Quality Index, SF-36 36-item Short Form Health Survey
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Each scan consists of six axial slices, with the first slice
placed in the medial tibia plateau. Each slide is 8 mm
thick and separated by a 60-mm gap as shown in Fig. 4.
The primary time interval for assessment is from base-
line to 12 months.
Secondary outcomes
Thigh isometric peak torque After having the partici-
pant perform a brief warm-up on a cycle ergometer, a
tester will measure the dominant thigh peak strength
at 70-degree flexion (0 degrees represents horizontal)
in a Kinetic Communicator (model 500-11, Kinetic
Communicator; Isokinetic International, Chattanooga,
TN, USA) with verbal encouragement. An investigator
will choose the best of three sweeps (i.e., highest peak
force) for analysis. The rate of force development and
impulse will also be analyzed [51, 64].
Thigh isokinetic peak torque Using the same settings
as those used for the isometric peak strength exercise,
the same tester will measure the dominant thigh isokin-
etic (at 60 degrees/second) force. With verbal encour-
agement, participants will perform maximal sweeps until
Fig. 4 Magnetic resonance imaging analysis. We place slices as shown for analysis of cross-sectional area of the m. quadriceps femoris muscle
and analyze slices 3 (counting in distal to proximal direction) and 4 for all subjects, and we use slice 4 for primary outcome evaluation. We fix the
placement of slices in absolute distances, but we measure the femur length on dual-energy X-ray absorptiometric scans from the lateral tibial
plateau (0 %) to the top of the greater trochanter (100 %) to report the relative placement of slices. Currently, placement of slice 3 ranges from
27 % to 36 % and slice 4 from 40 % to 54 % of the femoral length, depending on the height of the participant
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peak values decline markedly from the best sweep on
that particular test day, and the test is finished. An in-
vestigator will choose the best sweep (i.e., highest peak
torque) and analyze the peak torque, total work, and
angle at peak torque [51, 64].
Power rig After recording the isometric and isokinetic
peak torques, the tester will measure the maximum
single-leg extensor power of the dominant leg using a
University of Nottingham leg extensor power rig accord-
ing to procedures described elsewhere [65]. This test is
known to correlate with physical performance [8] even
more than muscle strength [66] and serves to link the
changes in strength to functional outcomes. During the
test, participants are in a seated position, and a single
maximum explosive leg extension accelerates a flywheel
from rest. A computer calculates the power of the leg
extensors on the basis of the speed of the flywheel. The
participants familiarize themselves with the procedure
by performing two warm-up trials followed by a mini-
mum of five and a maximum of ten maximal trials with
approximately 30 seconds of rest between them.
30-second chair-stand The 30-second chair-stand test
is a functional assessment of strength and endurance in
the lower extremity by measuring the number of stands
completed in 30 seconds with hands crossed on the
chest [67]. The test is useful in characterizing the partic-
ipant’s functionality and is also known to correlate with
daily activity level [68].
Muscle biopsies and fiber-type composition Working
in sterile conditions, a qualified researcher will obtain
muscle biopsies from the dominant m. vastus lateralis
ad modum Bergström [69] with suction using the local
anesthetic lidocaine 1 %. One biopsy is taken before and
one after 12 months of the intervention, approximately
2–3 cm apart in a proximal-to-distal direction.
Body composition A trained operator will perform
whole-body DXA using the enCORE v.16 software
(Lunar iDXA; GE Medical Systems, Pewaukee, WI,
USA). Participants arrive having refrained from solid
foods from 21:00 the day before the baseline and 12-
month scans, and we perform scanning between 08:00
and 10:00. We obtain the remaining scans in the fed
state at all times of the day, but prior to all scans partici-
pants are euhydrated and instructed to void. Whole-
body composition is autoanalyzed, and, on a separate oc-
casion, a blinded investigator performs separate thigh
analyses manually with a region of interest (ROI) defined
proximally by drawing a horizontal line laterally from
the distal part of the groin and distally by drawing a line
horizontally through the medial tibial plateau [70–72].
The thigh ROIs are equal in size in each subject but vary
with thigh length between subjects.
Bone mineral density In the same baseline and 12-
month DXA sessions, the same operator scans the bone
mineral density in the lumbar region (L2–L4) and the
dominant collum femoris. The investigator will place the
vertebral ROI as caudal as possible, including the discus
caudal to the vertebra, making sure not to include the
adjacent vertebra or spinous process. On the collum
femoris scan, the investigator places the ROI as distal
as possible without including the greater trochanter
[73, 74].
Gut microbiome At 0, 6, and 12 months, participants
place a fecal sample in an insulated bag with freezer ele-
ments until delivery at Bispebjerg Hospital within 48 h.
The container is then stored at −60 °C until further ana-
lysis. Following homogenization, we extract the total
DNA using the PowerSoil DNA isolation kit (MO BIO
Laboratories, Carlsbad, CA, USA) with an initial bead-
beating step and employ tag-encoded 16S ribosomal
RNA gene (prokaryotes) and internal transcribed spacer
region (eukaryotes) high-throughput sequencing using
the MiSeq platform (Illumina, San Diego, CA, USA) to
characterize the prokaryotic and eukaryotic components
of the gut microbiome. As previously reported [75], we
purify, extract, and sequence the virus-like particles for
characterization of the gut virome.
Fecal metabolome We will analyze the fecal metabolite
extracts by performing gas chromatography with time-of-
flight mass spectrometry (GC-TOF-MS) and nuclear mag-
netic resonance (NMR) spectroscopy using the same me-
tabolite extract. The extraction procedure will involve
stabilization of the homogenized fecal samples in PBS
(pH 7.4) followed by freeze-drying and subsequent resus-
pension in methanol. We will perform untargeted meta-
bolomics analysis and targeted profiling of short-chain
fatty acids with a high-throughput GC-TOF-MS setup
consisting of an Agilent 7890B gas chromatograph
(Agilent Technologies, Santa Clara, CA, USA) and a high-
throughput Pegasus TOF-MS spectrophotometer (LECO,
St. Joseph, MI, USA). To increase GC-TOF-MS sensitivity
toward a broad spectrum of nonvolatile metabolites, we
will derivatize the samples as previously described [76]
followed by processing of the obtained complex raw data
using state-of-the-art three-way decomposition methods
with Parallel Factor Analysis 2 [77]. We will further
stabilize the fecal metabolite extracts using PBS prior to
performing one-dimensional 1H NMR measurements
using an AVANCE III 600 spectrometer (Bruker BioSpin
GmbH, Rheinstetten, Germany) operating at a Larmor
frequency of 600.13 MHz for protons and equipped with a
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cooled high-capacity autosampler (SampleJet; Bruker
BioSpin GmbH) [78].
Plasma metabolome We will collect the plasma sam-
ples with participants in fasting condition prior to the
oral glucose tolerance test (OGTT) at 0 and 12 months
and in fed condition at 6 and 18 months. Researchers
will draw the blood into two containers, one containing
tripotassium ethylenediaminetetraacetic acid (K3-EDTA)
and one with heparin, and, after centrifugation at
3970 rpm for 10 minutes at 4 °C, we will pipette plasma
into vials that are stored at −60 °C. We then will per-
form untargeted metabolomics of all samples using pro-
ton one-dimensional 1H NMR spectroscopy and for a
subset of the samples by GC-TOF-MS.
We will perform the NMR measurements according to
standard operating procedures developed for NMR
metabolomics of plasma samples [79], and the data will
provide unbiased metabolic fingerprints of the plasma
samples, including information about lipoprotein par-
ticle distribution [80]. Prior to GC-TOF-MS analysis, we
will thaw, vortex, and centrifuge the plasma samples at
room temperature followed by addition of ice-cold
acetonitrile in 1:3 (vol:vol) to precipitate proteins. Imme-
diately after this, we will vortex the samples vigorously
and centrifuge them at 20,000 × g for 10 minutes at 4 °C,
and we will then dry 50 μl of clear supernatant under re-
duced pressure, derivatize it as described previously [76],
and subject it to GC-TOF-MS.
Muscle protein synthesis To assess MPS, we will per-
form an 8.5-h primed, continuous infusion of a stable
isotope-labeled amino acid tracer, L-[ring-13C6]phenyl-
alanine (Cambridge Isotope Laboratories, Tewksbury,
MA, USA) at baseline and after 12 months of the inter-
vention in a random subset of participants from each of
the five intervention groups. The participants will fast
overnight fast, and we will start the tracer infusion
followed by collection of muscle biopsies after 1.5-h and
4.5-h infusions to measure the basal resting MPS over a
3-h period. Thereafter, we provide a protein drink as a
beverage containing 20 g of whey hydrolysate plus 10 g
of maltodextrin followed by collection of the third
muscle biopsy. After an additional 4 h, we will measure
the postprandial response of MPS. We will sample the
muscle biopsies from the m. vastus lateralis muscle ap-
proximately 3 cm apart in a proximal-to-distal direction.
Throughout the day, we will collect venous blood sam-
ples to measure tracer enrichment as well as amino acid
and insulin concentrations, and we will measure the en-
richment of phenylalanine tracer in blood and free in
muscle cells by GC-MS/MS, whereas we will measure
the incorporation of labeled phenylalanine in muscle
proteins using GC-combustion/isotope ratio MS. We
will then calculate the fractional synthesis rate (FSR) as
the difference of incorporated tracer between subsequent
biopsies (Ep2 − Ep1) divided by the precursor enrichment
(Eprecursor; venous plasma and muscle free enrichment)
and divided by incorporation time: FSR (%/h) = [(Ep2 −
Ep1) × (Eprecursor)
−1 × (incorporation time)−1] × 100 %
[81]. This setup allows the evaluation of both basal MPS
and the MPS response to a protein/carbohydrate drink
before and after the 12-month intervention as a measure
of muscle anabolic responsiveness to intake of a single
protein supplement. We will also analyze muscle biop-
sies for relevant myocellular gene expression using real-
time reverse transcriptase-polymerase chain reaction
and for protein signaling through, for example, mamma-
lian/mechanistic target of rapamycin complex 1 by per-
forming Western blotting.
Tertiary outcomes
Blood parameters and anthropometry At baseline, we
will obtain standard health screening blood samples. At
the remaining time points, we will measure only plasma
HbA1c, cholesterol, and creatinine. Moreover, we will
measure body weight, waist, and hip circumference at
the remaining time points, whereas we will measure only
height at baseline. Participants will wear underwear only
when we measure body weight at baseline and
12 months, and they will wear light clothing at 6 and
18 months.
Hand grip strength We will evaluate hand grip strength
of the dominant hand (bilateral testing at baseline) by
using a hand grip strength dynamometer (DHD-1
[SH1001]; SAEHAN Corporation, Changwon City, South
Korea). The tester allows at least 30 seconds of rest be-
tween a minimum of three attempts, and the highest
value at the given time point is used. The test is finished
when two consecutive measurements are lower than the
peak value [82].
400-m walk test (fast gait speed) On a 20-m course
marked with two colored cones, the physical examiner
instructs the subject to walk 400 m as fast as possible
without personal support or sitting down. Up to 1 minute
of standing is permitted if the participant feels tired or
experiences discomfort, as long as the test is completed
within 15 minutes [83]. Among several functional mea-
sures, we chose 400-m gait speed as it is one of the more
demanding functional tests available for elderly popula-
tions. This minimizes the risk of a ceiling effect among
the included participants whom we expected to be rela-
tively well-functioning.
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Health-related questionnaires At baseline and
12 months, we will hand out Danish translations of the
36-item Short Form Health Survey [84] and the
Pittsburgh Sleep Quality Index [85], which the subjects
complete without further instructions.
Activity monitoring We measure 4-day (96-h) overall
activity by mounting an activity monitor (activPal 3™,
activPal 3c™, or activPal micro; PAL Technologies,
Glasgow, UK) on the anterior surface of the thigh. The
period always covers an entire weekend. An investigator
will analyze data quantified as step counts, time in sit-
ting/lying position, time in standing position, and time
walking [86, 87].
Weighed food registration We will administer a 3-day
weighed food and liquid registration from Wednesday to
Friday before, 4–6 weeks after, and 50 weeks after com-
mencing the intervention. Investigators subsequently will
quantify total daily intake and meal distribution of mac-
ronutrients using the MADLOG VITA system
(MADLOG ApS, Kolding, Denmark).
Sensory and hedonic evaluation questionnaires Par-
ticipants will complete a questionnaire about their ex-
perience with taking the dietary supplements. We will
collect baseline data on the first consumption day (day
0) and weekly for 12 weeks. Thereafter, we will reevalu-
ate participants every third month until week 52. The
flavor of the supplements will be alternated every week
between fruit and cacao, and the participants will fill in
the questionnaires within 1 minute after ingestion of the
supplement. We will measure the participants’ accept-
ance after the first sip and after complete consumption
on a 9-point hedonic scale ranging from 1 = “do not like
at all” to 9 = “like a lot,” with neutral in the middle. After
the first sip, we will record the participants’ perceived
experiences using the check-all-that-apply method with
20 attributes of taste, flavor, mouth feel, and sensory ap-
peal of the dietary supplement. After participants con-
sume the supplements, we will collect data on how
satiating, refreshing, and easy to drink it was, as well as
on the strength and persistence of the aftertaste on a 9-
point scale ranging from 1 = “completely disagree” to 9
= “completely agree,” with neutral in the middle.
Satisfaction with Food-related Life scale Subjects will
complete the Satisfaction with Food-related Life scale
[88] on days 0, 90, 180, and 360 to identify factors con-
tributing to satisfaction with food-related lifestyle.
Oral glucose tolerance test Participants will undergo
two OGTTs during the study. Participants will fast over-
night, and a researcher will draw a basal venous blood
sample and then administer 75 g of anhydrous glucose
dissolved in 250 ml of tap water. Subsequently, the re-
searcher will draw blood at 45 and 120 minutes after
consumption of the glucose. Participants will lie supine
throughout the 2-h period [89]. We will draw blood in
K3-EDTA vials and cool the vials for at least 15 minutes,
centrifuge the sample for 10 minutes at 3970 rpm at 4 °
C, immediately analyze the plasma for glucose, and store
aliquots at −80 °C for subsequent insulin measurement.
At baseline, we draw two further blood samples in K3-
EDTA and heparin vials respectively, which are cooled
on ice, centrifuged for 10 minutes at 3172 × g, and the
plasma is then stored at −60 °C until metabolome
analysis.
Qualitative interviews and observations
Qualitative interviews Upon participant inclusion, a re-
searcher will conduct a short, standardized, qualitative
interview with the participant to gain information on
marital status, living conditions, work life, hobbies, and
dietary preferences. At the 18-month follow-up, a re-
searcher will interview the participants to gain informa-
tion about their experience with the intervention and
current habits regarding nutrition and exercise.
Questionnaire on food habits At baseline, the staff will
hand out a questionnaire with a range of questions
about the food perceptions and habits of the participant.
The questionnaire combines basic socioeducational data,
quantitative questions, and quantifiable qualitative ques-
tions about lifestyle changes, dietary changes and per-
ceptions, and intake of protein-rich foods. The
participants can complete the questionnaires during the
first 3 months and subsequently hand them in.
Life story interviews We will select 25 of the interven-
tion participants for 1.5- to 2.5-h life story/trajectory in-
terviews in their own homes. The main themes of the
interviews are past and present perceptions of and habits
concerning food and physical activity, but we will also
include questions regarding mobility and work life.
Ethnographic fieldwork We will select 48 research par-
ticipants to engage in a qualitative study focused on
everyday life routines, eating practices, physical activity,
and experiences with participating in the trial. We do
this by observing the research participants in their
homes and at the site of the clinical trial, thereby follow-
ing their daily activities in both settings. Further, we will
conduct semistructured qualitative interviews to gain in-
depth knowledge about selected individuals.
Bechshøft et al. Trials  (2016) 17:397 Page 12 of 17
Data collection, management, and analysis
According to Danish research ethics legislation, we will
inform the participants about their rights as voluntary
subjects in a scientific trial and interview them about
their motivation for participation. We do this to make
participants consider participation thoroughly to dimin-
ish the likelihood of their dropping out. We are obliged
to report any unforeseen adverse effects due to partici-
pation to the local ethical committee, which will con-
sider terminating the project depending on the reported
incidents.
We will collect and manage study data using REDCap
electronic data capture tools hosted at RegionH
(Copenhagen, Denmark) [90] and secure it according to
Danish Data Protection Agency legislation (approval on
9 January 2015, number 2012-58-0004 – BBH-2015-001
I-Suite 03432). This includes pseudoanonymization of
sensitive data. Only relevant staff have logged access to
the key file.
The project has a scientific advisory board with ex-
perts from all scientific disciplines applied in the re-
search, and its members meet annually with the
researchers to discuss progress and plan future work.
The board members are financially and personally unre-
lated to the study investigators and the project as such.
The principal investigators from each scientific discip-
line have a shared responsibility to secure and monitor
data collection and interpretation, and thus they are all
involved in project management, analysis of samples,
data collection, and observations and will all have access
to the final dataset and jointly be involved in the inter-
pretation of results.
Statistics and power calculations
For all power calculations, we will apply a level of sig-
nificance of 0.05 and a power of 0.80, and the primary
outcome is the degree of muscle hypertrophy deter-
mined as the change in quadriceps muscle CSA on MRI
scans over the course of the 12-month intervention. On
the basis of previous data [91], we set the following pa-
rameters: least average expected change over the course
of the 12-month intervention between distinct interven-
tion groups, 300 mm2 (corresponding to an estimated
relative change of 6.5 %) with a SD set to 140 mm2. Our
goal is to be able to detect differences between groups’
mean hypertrophy down to approximately 2 %, which
corresponds to approximately 80 mm2. A difference in
the change of quadriceps muscle CSA greater than
80 mm2 between any two groups is statistically detect-
able with a power of at least 0.80 with a group size of
30. We decided to include 35 subjects in each of the
three groups (HRTW, LITW, and CARB), as we antici-
pated a dropout rate of 15 % at the time of study initi-
ation. In the WHEY and COLL groups, we expected a
larger dropout rate because of taste issues with protein
supplements and no motivational effect by training as in
the HRTW and LITW groups. Thus, we will include 50
each in the WHEY and COLL groups. On an ad hoc
basis, we will evaluate the actual dropout rate and adjust
the total number of inclusions accordingly.
In a subset of participants from the five intervention
groups, we will conduct experimental tracer studies be-
fore and after the 12-month intervention period to de-
termine the extent to which the interventions affect the
responsiveness of MPS to protein intake. The goal is to
measure whether any of the interventions enhance the
anabolic sensitivity to protein intake and thereby investi-
gate if we can link the observed differences in muscle
mass over the course of the intervention period to
changes in the anabolic response to protein feeding.
Thus, the outcome measure is the relative change in the
FSR of muscle proteins from the basal condition, defined
as the overnight fasted and resting state, to the average
4-h postprandial period after intake of a standard pro-
tein bolus. We are not aware of any data on changes in
MPS responsiveness over time, and we therefore based
the power calculations on a sum of our own published
and unpublished data obtained in healthy elderly partici-
pants. We established the following parameters: ex-
pected average 4-h postprandial responsiveness to
protein feeding from basal condition of 0.016 %/h (i.e.,
approximately corresponding to an increase in muscle
protein FSR of 50 %) with an interparticipant SD on the
increase of 0.017 %/h. We aim to be able to detect a
50 % change in responsiveness within a group over
the course of the 12-month period (i.e., a change of
0.008 %/h in the increase in the muscle protein FSR
from 0.016 %/h to 0.024 %/h). The SD for the change
in responsiveness is set as 0.006 %/h. By including
10–12 participants, we obtain a power of at least 0.80
to detect a statistical difference over time within each
intervention group. By taking the probability of drop-
outs into account, we decided to include 12 partici-
pants in the HRTW, LITW, and CARB groups and
15 in the WHEY and COLL groups, respectively.
Investigators will analyze data as intention-to-treat
(except in subgroup analyses) as well as per protocol,
and we will test the following groups against each other
using one-way analysis of variance of the relative group
changes from baseline to 12 months: (1) WHEY vs.
COLL vs. CARB and (2) HRTW vs. LITW vs. WHEY.
We will not conduct any interim analyses in this project.
Discussion
The inclusion rate is currently 15 %, and we have been
in contact with more than 1000 elderly individuals,
recruiting approximately 150 participants. The major
challenge until now has been to find elderly individuals
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who are willing to be committed to participate for
18 months as well as accept the outcome of the
randomization. The interventions are very different in
terms of time required for the intervention as well as
potential physical and social gain. The three
supplementation-only groups demand less time, but the
candidates expect less gain from the intervention than
those in the more time-consuming physical training
groups, so the main reasons for candidates to decline
participation is the uncertainty of the randomization.
This has resulted in roughly 45 % of candidates having
decided to refrain from volunteering. Second, our exclu-
sion criteria are numerous in order to ensure accurate
results, and we have excluded around 40 % of the poten-
tial participant population for this reason, leaving for in-
clusion 15 % of those who had initially contacted us.
The invasive procedures and number of tests are not is-
sues of major importance for the participants when we
are recruiting. Fortunately, the dropout rate until now
has been very low: Only 4.3 % have ceased participation,
which is far less than the initially expected rate of 10–
15 %. We recruit research participants for this study in
the Capital Region of Denmark. The population in this
region is wealthier [92], and likely also healthier, than
the general population in Denmark, but for practical
reasons we could only recruit participants locally. This
represents a possible selection bias in the trial.
Safety issues and dropout rate
We consider the project safe, and the clinical staff rou-
tinely perform the tests and invasive procedures used.
We supervise participants during heavy strength training
and carefully instruct them in the light load training
exercises. The nutrient supplements contain 510 kJ (i.e.,
a dose of 1020 kJ/day) and induce mild satiety when
ingested. Therefore, we expect a slight decrease in the
participants’ habitual diet corresponding to the energy
content in the supplements, and we expect their body
weight to be stable. We control HbA1c, creatinine, and
cholesterol levels after 6 months to ensure that partici-
pants do not develop insulin resistance, impaired kidney
function, or hyperlipidemia because of supplement
intake. In case of adverse events, the Danish Patient
Compensation Association covers participants’ treat-
ment needs.
Perspectives
The purpose of the CALM Intervention Study is to pro-
vide interdisciplinary knowledge on the efficacy and
feasibility of daily protein supplementation and muscular
exercise training in different settings to support the
maintenance of skeletal muscle mass in the elderly to
ensure daily functional capacity and maintain or improve
quality of life. Until now, only a few studies have
investigated the physiological outcome of strength train-
ing and protein supplementation, and, to our knowledge,
a light intensity strength training regime has never been
investigated. Further, the interdisciplinary setting, in-
cluding sensory, fecal, and qualitative investigations, will
provide unique insights into how to counteract the age-
related loss of skeletal muscle mass.
A key assumption in the CALM Intervention Study is
that an improved adherence to a healthier lifestyle re-
quires sensitivity to the everyday lives, routines, and cul-
tural differences of the research participants [93]. We
aim to enhance this sensitivity by gathering qualitative
knowledge on the societal, cultural, and individual fac-
tors that influence daily routines related to nutrient con-
sumption and exercise to identify and circumvent the
barriers that complicate changes in these. We will per-
form an exploration of societal and individual influences
on everyday lifestyle habits and of how the project con-
figures the participants’ everyday food and exercise prac-
tices. Further, we will investigate how participants’
practices are (and are not) transformed by their interac-
tions with the materiality as well as the scientific practi-
tioners and attitudes of the project to provide insights
that potentially could improve health promotion strat-
egies [94].
We expect to translate the results of this into guide-
lines targeted to the home-dwelling, independent elderly
population and disseminate them to the public through
channels involving nongovernmental organizations,
newspapers, electronic media, and stakeholders in, for
example, the municipalities. The CALM Intervention
Study will provide novel information on the potential
longitudinal benefits of protein supplementation and
strength training regarding physical performance, gut
microbiota, and overall health while taking into account
the feasibility and impact of the interventions on every-
day life.
Trial status
Since we began advertising for participants in January
2014, we have recruited and randomized 153 (as of 1
August 2016). A total of 54 and 32 participants have
completed the intervention and follow-up, respectively.
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